ANXA1 and Stroke: Reduced AnxA1 levels were found in both, IS patients and mouse models for IS and administration of AnxA1 offered protection against IS damage (by its ability to reduce cerebral thrombosis, a prerequisite for stroke) and against subsequent thrombotic events post-stroke, an effect involving inside-out integrin signaling events in platelets99.